When both conditions occur together, the risk of heart disease, stroke, kidney disorders, and certain cancers increases
On the other hand, disturbances observed in the course of depression do not clearly indicate whether they are the effects of disruption of metabolic processes in the brain
Likewise, certain racial groups (e.g., Hispanic, non-Hispanic Black) are often more affected by obesity and more likely to have lower incomes relative to other groups (e.g., white, Asian)
How GLP-1 Agonists Enhance Fat Loss GLP-1 (Glucagon-Like Peptide-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), are medications initially developed for diabetes management but have gained widespread popularity for their weight-loss benefits
For patients with type 2 diabetes, Ozempic (semaglutide) can be a valuable part of their treatment regimen, as a glucagon-like peptide-1 (GLP-1) receptor agonist, Ozempic works by enhancing the bodys natural insulin response, helping to lower blood sugar levels and promote weight loss